PharmaBoardroom’s Top Five Op-Eds of 2021

main_img

PharmaBoardroom’s network of thought leaders provided some of our best-read content in 2021 on topics ranging from China’s National Reimbursement Drug List to the vaccine row that erupted between AstraZeneca and the EU, the skills that pharma leaders need in the MEA region, the year’s most prominent trends, and how AI stands to transform market access. See our dedicated op-ed page for all of last year’s contributions and stay tuned for more in 2022!

China’s National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?

Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation

The Skills That Regional Pharma Leaders Need in the Middle East & Africa

Five Trends for Life Science Companies to Watch in 2021

Five Ways That AI Can Transform Pharma Market Access


Related Content


Latest Report